CHARLES BOYER: Open Payments
NPI 1538298062 · GROVE CITY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 16 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $112 · 2025 $157
Food & beverage: $132Education: $25
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Travere Therapeutics, Inc. | 10 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| AKEBIA THERAPEUTICS INC | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
| Mannkind Corporation | 1 | $14 |
Products named: JYNARQUE, Filspari, Fabhalta, Vafseo, TARPEYO, AFREZZA.
Industry payments across OH — which companies pay providers there.
